Summary
62 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $69.1M in the last fiscal year, 24% of its market value.
What to watch
- Earnings per share fell by 28% a year over the last 3 years.
- Out of every 100 USD of revenue, only 5.9 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Information Technology Services)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 17.2 USD for 1 USD of yearly profit. Over the last five years it was 24.4 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.0% a year over 5 years. Over the last 3 years it grew by 1.3% a year. Earnings per share fell by 28% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 59 USD
- Sales and administration 28 USD
- Taxes and other 6.8 USD
- Net profit 5.9 USD
Net profit, industry median (Information Technology Services) 15 USD
Out of every 100 USD of revenue, 5.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 4.18%
- Paid out of profit
- 72%
- Raised in a row
- 1 year
You receive $0.48 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $16.5 is 44% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Revenue Before Reimbursements 98%
- Reimbursements 1.6%
By region
- UNITED STATES 81%
- Europe 11%
- Other Australia Canada India And Uruguay 8.3%
Revenue Before Reimbursements brings in 98% of revenue. Reimbursements grew fastest, by 41% a year.
Segments in detail